Core Insights - HeartSciences Inc. has partnered with the University of the West of England to establish a Reference Center for ECG Education and Technology, utilizing its MyoVista Insights™ platform and MyoVista® wavECG™ device as exclusive ECG technologies [1][2][3] Group 1: Partnership and Technology Adoption - The MyoVista Insights and MyoVista wavECG device will be exclusively used in UWE's cardiac and physiological science teaching programs, aimed at training future cardiac scientists [2] - This partnership supports NHS England workforce priorities and enhances the UK's cardiac diagnostic capacity [2][3] Group 2: Educational Impact - The establishment of the UWE ECG Education and Technology Reference Center will serve as a nationally aligned academic reference site, facilitating clinical adoption discussions with NHS trusts and providing real-world validation of MyoVista Insights™ [3] - The MyoVista Insights platform is noted for advancing ECG analysis beyond traditional methods, enhancing student engagement and understanding of cardiac electrophysiology [4] Group 3: Strategic Positioning - The collaboration reinforces HeartSciences' long-term commercial positioning within the UK healthcare ecosystem, creating a strategically important reference site for broader engagement with the NHS [3][4] - The CEO of HeartSciences expressed satisfaction with the partnership, highlighting its significance for clinical and educational value [4]

Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has launched the MyoVista InsightsTM platform and related early adopter program for select reference sites. MyoVista Insights is a cloud-native next-generation ECG Management System designed to enhance ...